Target Name: KIAA0513
NCBI ID: G9764
Review Report on KIAA0513 Target / Biomarker Content of Review Report on KIAA0513 Target / Biomarker
KIAA0513
Other Name(s): KIAA0513 variant 1 | Uncharacterized protein KIAA0513 | Uncharacterized protein KIAA0513 (isoform a) | K0513_HUMAN | KIAA0513, transcript variant 1

KIAA0513: Role in Cell Adhesion, Migration and Invasion

KIAA0513 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the Kallikrein family of proteins, which are involved in the regulation of extracellular matrix (ECM) components. KIAA0513 has been shown to play a role in the regulation of cell adhesion, migration, and invasion, and is often used as a drug target or biomarker in various diseases.

One of the key functions of KIAA0513 is its role in cell adhesion. At the cell surface, KIAA0513 is involved in the formation of tight junctions, which are specialized barriers that regulate the movement of cells and allow for the exchange of nutrients and waste products. In addition, KIAA0513 is involved in the regulation of cell migration, which is the movement of cells from one location to another in the body. This is important for the development and maintenance of tissues and organs, and is also involved in the treatment of various diseases, such as cancer.

Another function of KIAA0513 is its role in the regulation of cell invasion. In addition to its role in cell adhesion, KIAA0513 is also involved in the regulation of cell invasion. This is the ability of cells to migrate through the ECM and into surrounding tissues. KIAA0513 has been shown to play a role in the regulation of cell invasion, and is often used as a drug target or biomarker in various diseases, such as cancer.

In addition to its role in cell adhesion and migration, KIAA0513 is also involved in the regulation of inflammation. This is important for the immune response and the regulation of tissue repair. KIAA0513 has been shown to play a role in the regulation of inflammation, and is often used as a drug target or biomarker in various diseases, such as rheumatoid arthritis.

KIAA0513 has also been shown to play a role in the regulation of cell survival. This is important for the regulation of cell division and the maintenance of tissue homeostasis. KIAA0513 has been shown to play a role in the regulation of cell survival, and is often used as a drug target or biomarker in various diseases, such as cancer.

In conclusion, KIAA0513 is a protein that is involved in a variety of physiological processes in the body. Its role in cell adhesion, migration, invasion, and inflammation makes it an attractive drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand the role of KIAA0513 in the regulation of cell processes and its potential as a drug or biomarker.

Protein Name: KIAA0513

The "KIAA0513 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA0513 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KIAA0586 | KIAA0753 | KIAA0754 | KIAA0825 | KIAA0930 | KIAA1107 | KIAA1143 | KIAA1191 | KIAA1210 | KIAA1217 | KIAA1328 | KIAA1522 | KIAA1549 | KIAA1549L | KIAA1586 | KIAA1614 | KIAA1656 | KIAA1671 | KIAA1671-AS1 | KIAA1755 | KIAA1958 | KIAA2012 | KIAA2013 | KIAA2026 | KICS2 | KIDINS220 | KIF11 | KIF12 | KIF13A | KIF13B | KIF14 | KIF15 | KIF16B | KIF17 | KIF18A | KIF18B | KIF19 | KIF1A | KIF1B | KIF1C | KIF20A | KIF20B | KIF21A | KIF21B | KIF22 | KIF23 | KIF23-AS1 | KIF24 | KIF25 | KIF25-AS1 | KIF26A | KIF26B | KIF27 | KIF28P | KIF2A | KIF2B | KIF2C | KIF3A | KIF3B | KIF3C | KIF4A | KIF4B | KIF5A | KIF5B | KIF5C | KIF6 | KIF7 | KIF9 | KIF9-AS1 | KIFAP3 | KIFBP | KIFC1 | KIFC2 | KIFC3 | Killer Cell Immunoglobulin-Like Receptor (KIR) | Killer cell immunoglobulin-like receptor 2DS1, transcript variant X1 | KIN | Kinesin-like protein KIF16B (isoform 1) | KIR2DL1 | KIR2DL2 | KIR2DL3 | KIR2DL4 | KIR2DL5A | KIR2DL5B | KIR2DP1 | KIR2DS1 | KIR2DS2 | KIR2DS3 | KIR2DS4 | KIR2DS5 | KIR3DL1 | KIR3DL2 | KIR3DL3 | KIR3DP1 | KIR3DS1 | KIR3DX1 | KIRREL1 | KIRREL1-IT1 | KIRREL2 | KIRREL3